相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years
L. Robertson et al.
BRITISH JOURNAL OF CANCER (2012)
Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study
Weifin Zeng et al.
Journal of Cancer (2012)
Malignant Rhabdoid Tumors Express Stem Cell Factors, Which Relate To the Expression of EZH2 and Id Proteins
Sriram Venneti et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
Soley Bayraktar et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Clinical Outcome of Triple Negative Breast Cancer in BRCA1 Mutation Carriers and Noncarriers
Larissa J. Lee et al.
CANCER (2011)
ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
Hye-Min Jeon et al.
CANCER RESEARCH (2011)
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers
Amandine I. Garcia et al.
EMBO MOLECULAR MEDICINE (2011)
MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development
Holger Heyn et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
D. G. Evans et al.
JOURNAL OF MEDICAL GENETICS (2011)
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
Eugenio Maiorano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
So Yeon Park et al.
CLINICAL CANCER RESEARCH (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast
Semir Vranic et al.
MODERN PATHOLOGY (2010)
Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels
P. M. Kuzontkoski et al.
ONCOGENE (2010)
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
S. R. Young et al.
BMC CANCER (2009)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
Triple negative breast cancers: Clinical and prognostic implications
S.J. Dawson et al.
EUROPEAN JOURNAL OF CANCER (2009)
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Giulia Fontemaggi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
Erik Noetzel et al.
BMC CANCER (2008)
Increased expression of Id family proteins in small cell lung cancer and its prognostic significance
Laleh Kamalian et al.
CLINICAL CANCER RESEARCH (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression
E. A. Rakha et al.
HISTOPATHOLOGY (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike et al.
BREAST CANCER RESEARCH (2007)
Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma
Paola de Candia et al.
HUMAN PATHOLOGY (2006)
Metaplastic breast carcinomas are basal-like tumours
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer
N Umetani et al.
ONCOGENE (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
L Yu et al.
NATURE GENETICS (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects
MF Nielsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis
N Umetani et al.
CLINICAL CANCER RESEARCH (2004)
The spectrum of apocrine lesions of the breast
FP O'Malley et al.
ADVANCES IN ANATOMIC PATHOLOGY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
ASW Chan et al.
ONCOGENE (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis
PL Welcsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Role of Id proteins in embryonic and tumor angiogenesis
R Benezra
TRENDS IN CARDIOVASCULAR MEDICINE (2001)
Centrally necrotizing carcinomas of the breast - A distinct histologic subtype with aggressive clinical behavior
RE Jimenez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach
C Beger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases
H Tsuda et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
分享论文
